Blair William & CO Sage Therapeutics, Inc. Transaction History

Blair William & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$60.18 - $154.77 $113,619 - $292,205	-1,888 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $21,043 - $28,494	-150 Reduced 7.36%	1,888 $265,000
Q2 2019 Aug 13, 2019	BUY	$157.85 - $183.09 $63,140 - $73,236	400 Added 24.42%	2,038 $373,000
Q1 2019 May 14, 2019	BUY	$89.33 - $163.65 $146,322 - $268,058	1,638 New	1,638 $261,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $284M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.